Avantor
- Market cap
- 10.38B
- P/E (TTM)i
- -18.06
- P/Bi
- 1.84
- EPSi
- -0.78
- Div yieldi
- 0.00%
- 52W posi
- 89%
Anonymous reader poll. Unscientific, not investment advice.
About Avantor
Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. Its portfolio includes biopharma, healthcare, education and government, as well as advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The company operates through the Laboratory Solutions segment and Bioscience Production. The Laboratory Solutions segment focuses on research, diagnostic, and quality control workflows. The Bioscience Production segment focuses on high-purity materials for bioprocessing and medical technologies. Avantor was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.
- Founded
- 1904
- CEO
- Mr. Emmanuel Ligner
- Employees
- 13,500
- Headquarters
- Radnor, Pennsylvania, United States of America
- Fiscal year end
- 12-31
- Website
- avantorsciences.com
Company profile
- Exchange
- US
- Symbol
- AVTR
- Market-cap rank
- #1438
- Listing date
- 2019-05-17
- Market cap
- 10.38B
- Float cap
- 10.10B
- Shares out
- 676.36M
- Float shares
- 657.80M
Sectors & themes
Quote time 2026-10-08 09:16:32 · For reference only, not investment advice and not tailored to your situation.